SA PRO
Free Account
ADMA Biologics, Inc.ADMANASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating
Buy
9 analysts·Limited coverage
100%
Rating Distribution
Strong Buy
111%
Buy
889%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Oct 14, 2024H.C. Wainwright
H.C. Wainwright Reiterates Buy Rating on ADMA Biologics (ADMA)
Target:$18.00
+5.0%from $17.14
Jun 20, 2024Mizuho Securities
ADMA Biologics (ADMA) PT Raised to $14 at Mizuho
Target:$14.00
+31.8%from $10.62
Jan 3, 2023H.C. Wainwright
HC Wainwright & Co. Maintains Buy on ADMA Biologics, Raises Price Target to $4.5
Target:$4.50
+16.0%from $3.88
Nov 10, 2022Mizuho Securities
Mizuho Maintains Buy on ADMA Biologics, Raises Price Target to $6
Target:$6.00
+96.7%from $3.05
Jul 25, 2022H.C. Wainwright
HC Wainwright & Co. Maintains Buy on ADMA Biologics, Lowers Price Target to $4
Target:$4.00
+84.3%from $2.17

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance